Skip to main content
GutCited

Psyllium Husk pour Irritable Bowel Syndrome (IBS)

B

ACG recommends soluble fiber (psyllium) over insoluble fiber for IBS. Improves global IBS symptoms with particular benefit in IBS-C. NNT of 7 for global symptom improvement.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'ingredient\u003Dpsyllium\u002Dhusk\u0026condition\u003Dibs'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

En conclusion

ACG recommends soluble fiber (psyllium) over insoluble fiber for IBS. Improves global IBS symptoms with particular benefit in IBS-C. NNT of 7 for global symptom improvement.

Key Study Findings

Observational Study n=97
Survey of Latin American gastroenterologists, specialists in disorders of gut-brain interaction, on the diagnosis and …
Dose: None vs: None Outcome: IBS management heterogeneity in Latin America Effet: None None

Population: Latin American gastroenterologists (DGBI specialists)

Review
The role of dietary fiber in the gastrointestinal tract: when, how and why?
Dose: None vs: None Outcome: None Effet: None None

Population: Review of dietary fiber role in GI tract

Randomized Controlled Trial 3 weeks Double-blind
Nutraceuticals and Pain Disorders of the Gut-Brain Interaction in Infants and Children: A Narrative Review …
Dose: None vs: Placebo Outcome: Pain outcomes Effet: None None

Population: IBS patients

Review
The role and therapeutic effectiveness of Plantago ovata seed husk (psyllium husk) in the prevention …
Dose: None vs: None Outcome: Colitis severity Effet: None None

Population: Ulcerative colitis patients

Systematic Review
[Phytotherapeutic recommendations in medical guidelines for the treatment of gastroenterological diseases - a systematic review].
Dose: Peppermint oil, STW-5, psyllium, others vs: Standard care or placebo Outcome: Symptom improvement in GI diseases Effet: None None

Population: Patients with gastroenterological diseases

Randomized Controlled Trial n=314
Sex-Dependent Efficacy of Dietary Fiber in Pediatric Functional Abdominal Pain.
Dose: Dietary fiber (psyllium) vs: Low fiber diet Outcome: Abdominal pain frequency Effet: None None

Population: Children with functional abdominal pain disorders

Key Statistics

8

Études

900

Participants

Positive

B

Note

Referenced Papers

The Medical letter … 2025
The Medical letter … 2020
International journal of … 2017 146 citations
Journal of gastroenterology … 2017 32 citations
Current opinion in … 2017 24 citations
International journal of … 2016 69 citations
Clinical gastroenterology and … 2016 2 citations
Digestion 2014 61 citations
The American journal … 2013 421 citations
Journal of clinical … 2011 30 citations
Alimentary pharmacology & … 2011 3 citations
Current opinion in … 2010 22 citations
Australian family physician 2009 12 citations
International journal of … 2007 375 citations
Current treatment options … 2006 24 citations
Biomedicine & pharmacotherapy … 1986 4 citations
Annals of internal … 1981 6 citations
JAMA 1964

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Posologies couramment utilisées

general:
5-10 g/day (with adequate water)
ibssupport:
5-10 g/day (start low, titrate up over 1-2 weeks)
constipation:
10-20 g/day in divided doses with at least 240 mL water per dose

Limite supérieure : Well-tolerated up to 30 g/day with adequate fluid intake

Posologies étudiées dans la recherche

Posologie Durée Effet N
None -- Mixed 97
None -- Mixed --
None 3 weeks Positive --
None -- Positive --
Peppermint oil, STW-5, psyllium, others -- Positive --
Dietary fiber (psyllium) -- Positive 314
2 g -- Mixed --
Low-FODMAP, probiotics, fiber -- Positive --

Moment optimal de prise : With meals and a full glass of water (240 mL minimum); space 1-2 hours from medications

Safety & Side Effects

Effets indésirables signalés

  • Gas and bloating (common initially; start with low dose and titrate up)
  • Esophageal/bowel obstruction if taken without adequate water (CRITICAL: always take with full glass of water)
  • Abdominal cramping at high initial doses
  • May reduce appetite (feeling of fullness)

Interactions connues

  • May reduce absorption of medications if taken simultaneously (space 1-2 hours)
  • Lithium (reduced absorption)
  • Carbamazepine (reduced absorption)
  • Diabetes medications (may enhance blood sugar lowering; monitor glucose)

Apport maximal tolérable : Well-tolerated up to 30 g/day with adequate fluid intake

Consultez toujours votre professionnel de santé avant de commencer tout complément alimentaire.Consultez toujours votre professionnel de santé avant de commencer tout complément alimentaire.

Frequently Asked Questions

Does Psyllium Husk help with Irritable Bowel Syndrome (IBS)?
Based on 8 studies with 900 participants, there is moderate evidence from clinical studies that Psyllium Husk may support Irritable Bowel Syndrome (IBS) management. Our evidence grade is B (Good Evidence).
How much Psyllium Husk should I take for Irritable Bowel Syndrome (IBS)?
Studies have used various dosages. A commonly studied range is 5-10 g/day (with adequate water). Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Psyllium Husk?
Reported side effects may include Gas and bloating (common initially; start with low dose and titrate up), Esophageal/bowel obstruction if taken without adequate water (CRITICAL: always take with full glass of water), Abdominal cramping at high initial doses, May reduce appetite (feeling of fullness). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Psyllium Husk and Irritable Bowel Syndrome (IBS)?
We rate the evidence as Grade B (Good Evidence). This rating is based on 8 peer-reviewed studies with 900 total participants. The overall direction of effect is positive.

Related Evidence

Avertissement FDA: Ces déclarations n'ont pas été évaluées par la Food and Drug Administration. Les produits et informations sur ce site ne sont pas destinés à diagnostiquer, traiter, guérir ou prévenir quelque maladie que ce soit. Les notes de preuve présentées sont basées sur notre analyse de la recherche publiée et évaluée par des pairs et ne constituent pas un avis médical. Consultez toujours votre professionnel de santé avant de commencer tout régime de compléments alimentaires.